GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,751,000 | -9.5% | 67,750 | -3.9% | 0.04% | -14.6% |
Q2 2017 | $3,041,000 | -1.9% | 70,518 | -4.1% | 0.05% | +2.1% |
Q1 2017 | $3,099,000 | +4.9% | 73,505 | -4.2% | 0.05% | +6.8% |
Q4 2016 | $2,955,000 | -34.0% | 76,746 | -26.0% | 0.04% | -37.1% |
Q3 2016 | $4,475,000 | -33.9% | 103,762 | -33.5% | 0.07% | -36.9% |
Q2 2016 | $6,766,000 | +9.3% | 156,113 | +2.2% | 0.11% | +6.7% |
Q1 2016 | $6,191,000 | +9.7% | 152,684 | +9.1% | 0.10% | -3.7% |
Q4 2015 | $5,645,000 | -0.1% | 139,898 | -4.8% | 0.11% | +0.9% |
Q3 2015 | $5,649,000 | -8.4% | 146,911 | -0.8% | 0.11% | +1.9% |
Q2 2015 | $6,169,000 | +2.9% | 148,108 | +14.0% | 0.10% | +2.9% |
Q1 2015 | $5,996,000 | +9.7% | 129,918 | +1.6% | 0.10% | +17.2% |
Q4 2014 | $5,466,000 | -11.0% | 127,887 | -4.3% | 0.09% | -5.4% |
Q3 2014 | $6,142,000 | -13.1% | 133,617 | +1.1% | 0.09% | -9.8% |
Q2 2014 | $7,068,000 | -7.4% | 132,154 | -7.5% | 0.10% | -13.6% |
Q1 2014 | $7,633,000 | +36.1% | 142,869 | +36.0% | 0.12% | +32.6% |
Q4 2013 | $5,609,000 | +43.3% | 105,066 | +34.7% | 0.09% | +39.1% |
Q3 2013 | $3,913,000 | +568.9% | 78,003 | +566.7% | 0.06% | +540.0% |
Q2 2013 | $585,000 | – | 11,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
Columbia Asset Management | 9,960 | $361 | 0.08% |
PARK CIRCLE Co | 800 | $29,000 | 0.03% |
PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
Retirement Group, LLC | 40 | $1,450 | 0.00% |
Bartlett & Co. LLC | 240 | $9 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |